Wesley Research Institute
Donate
Now

This one year research project aims to compare two commonly used methods of draining the effusion to determine which one is best.

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Pleural Effusion

Study location

Wesley Research Institute

Study type

Investigator Initiated
find out if you’re eligible

Lead investigator

  • Dr Luke Garske

Clinical trial coordinators

  • Chris Henderson
  • Linda Pearce

Technical title

AMPLE-3: A Randomised Study Comparing Combined Indwelling Pleural Catheter (IPC) and Talc Pleurodesis with Video-Assisted Thoracoscopic Surgery (VATS) for the Management of Patients with Malignant Pleural Effusion

About this research project

The lung is covered by a thin lining which produces a very small amount of fluid to lubricate the lungs during breathing. Cancers can spread to this lining causing a build-up of fluid. This is called a malignant pleural effusion. The increased fluid can compress the lungs causing breathlessness. Draining the fluid can ease symptoms but it usually rapidly re-accumulates and needs further drainages.

This one year research project aims to compare two commonly used methods of draining the effusion to determine which one is best. One method involves a surgical procedure (VATS) and the other involves insertion of a long-term flexible chest tube (IPC). IPC and surgical pleurodesis are known to be safe procedures and are both commonly used; however, no one knows if one is better than the other at preventing the fluid from returning and further procedures being required.

 

Latest News & Discoveries

Breakthrough Research Reveals Why Some Cancer Patients Respond to Immunotherapy While Others Don’t

In a groundbreaking study, Australian researchers at the Queensland Spatial Biology Centre (QSBC) have uncovered a crucial factor that determines whether patients with head and neck cancer will respond to immunotherapy - a finding that could pave the way for more effective treatments and improved survival rates.  

New Research Highlights the Potential of Private Virtual Hospitals to Improve Healthcare Access 

New research has revealed the immense potential of private virtual hospitals to transform healthcare delivery in Australia.  The study explores how these “hospitals without walls” can safely and effectively provide hospital-level care in patients’ homes, combining telehealth consultations, remote monitoring, and hybrid care approaches.

Wesley Research Institute’s First Coeliac Disease Webinar Series A Success

Wesley Research Institute’s inaugural Coeliac Disease Webinar Series has been met with an overwhelming response. The two-session event - one tailored for individuals living with coeliac disease and the other for clinicians - featured leading experts Dr James Daveson, Clinical Director of the Coeliac Research and Immune Health Program at Wesley Research Institute, and Dr Jason W. Chien, Chief Medical Officer at Mozart Therapeutics.
1 2 3 19
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram